Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 2/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.58 |
| ▸ | DRD2 | P14416 | 1/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.58 |
| ▸ | HTR2A | P28223 | 1/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.58 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6195133 | 0.95 | UTS2R (0.55) | UTS2RADRA2ADRD2SLC6A2HTR2A | |
| SCHEMBL6197447 | 0.93 | UTS2R (0.60) | UTS2RADRA2ADRD2SLC6A2HTR2A | |
| SCHEMBL6194423 | 0.92 | UTS2R (0.57) | UTS2RADRA2ADRD2SLC6A2HTR2A | |
| SCHEMBL6196864 | 0.92 | UTS2R (0.58) | UTS2RADRA2ADRD2SLC6A2HTR2A | |
| SCHEMBL6196172 | 0.92 | UTS2R (0.58) | UTS2RADRA2ADRD2SLC6A2HTR2A | |
| SCHEMBL6198255 | 0.91 | UTS2R (0.62) | UTS2RADRA2ADRD2SLC6A2HTR2A | |
| SCHEMBL6195032 | 0.91 | UTS2R (0.57) | UTS2RADRA2ADRD2SLC6A2HTR2A | |
| SCHEMBL6193137 | 0.91 | UTS2R (0.60) | UTS2RADRA2ADRD2SLC6A2HTR2A | |
| SCHEMBL6199812 | 0.91 | UTS2R (0.59) | UTS2RADRA2ADRD2SLC6A2HTR2A | |
| SCHEMBL6197438 | 0.90 | UTS2R (0.57) | UTS2RADRA2ADRD2SLC6A2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1499607-B1 | 4-(PIPERIDYL- AND PYRROLIDYL-ALKYL-UREIDO)-QUINOLINES AS UROTENSIN II RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2005-12-07 | — | — | EP | disclosed |